Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Merck sees potential U.S. authorization for COVID-19 antiviral before year-end

09/13/2021 | 12:13pm EDT

Sept 13 (Reuters) - Drugmaker Merck & Co Inc said on Monday it sees potential U.S. emergency use authorization for its experimental COVID-19 antiviral treatment, molnupiravir, before year-end.

"I would just say that our program is enrolling well, and we expect to be able to see clinical data in the back half of the year," Merck's Chief Executive Officer Robert Davis said at Morgan Stanley's Annual Global Healthcare Conference.

Merck and partner Ridgeback Biotherapeutics are conducting a late-stage trial of molnupiravir in non-hospitalized COVID-19 patients to see if it reduces the risk of hospitalization or death.

Merck in June said it expected to file for the emergency use authorization of molnupiravir in the second half of 2021 at the earliest. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)


© Reuters 2021
Latest news "Economy & Forex"
03:56pExclusive-Turkey's state banks likely to follow central bank and slash rates on Monday -sources
RE
03:54pIRBEA CONFERENCE WEBINAR SPECIAL 1 – COP26 GOAL 1 : securing global net zero by mid-century & keep 1.5 degrees within reach
PU
03:31pErdogan's critics say expulsion call is diversion from economic woe
RE
03:18pItaly, UniCredit fail to clinch Monte dei Paschi rescue deal
RE
03:14pU.s. cdc says as of october 24, 12,888,226 people received a booster dose for covid-19 vaccine since august 13, 2021
RE
03:14pU.s. cdc says 190,578,704 individuals have been fully vaccinated against covid-19 as of oct 24 vs 190,402,262 individuals as of oct 23
RE
03:14pU.s. cdc says 220,351,217 individuals have received at least one dose of covid-19 vaccine as of oct 24 versus 220,145,796 individuals as of oct 23
RE
03:13pU.s. cdc says administered 413,645,478 doses of covid-19 vaccine as of oct 24 vs 412,856,169 doses administered as of oct 23
RE
02:56pTurkish lira hits record low after Erdogan seeks expulsions
RE
01:55pElon Musk Says "None" When Asked How Much $Shib Is He Holding - Tweet
RE
Latest news "Economy & Forex"